Weight decrease improves live birth rates in obese women undergoing IVF: a pilot study
Juan J Espinós1, Ana Polo2, Juan Sánchez-Hernández3
1Department of Obstetrics and Gynaecology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Reproductive Biomedicine Online
|July 26, 2017
Summary
A 12-week diet and exercise program for obese women undergoing in vitro fertilization (IVF) significantly increased live birth rates. This intervention shows promise for improving fertility outcomes in overweight individuals.
Area of Science:
- Reproductive Endocrinology
- Obesity Medicine
- Clinical Nutrition
Background:
- Obesity is linked to reduced pregnancy rates in assisted reproductive treatments.
- Limited research exists on pre-IVF interventions for obese women.
Purpose of the Study:
- To assess the impact of a 12-week diet and exercise intervention on pregnancy rates in obese women undergoing IVF.
- To evaluate if pre-IVF lifestyle modification improves fertility outcomes.
Main Methods:
- Pilot study with 41 obese women undergoing IVF.
- Randomized controlled trial comparing an intervention group (diet and exercise) with a control group.
- Intervention included individualized diet and supervised physical activity for 12 weeks prior to IVF.
Main Results:
- The intervention group achieved a mean weight loss of 5.4 kg.
- Similar oocyte and embryo yields were observed between groups.
- A non-significant trend towards higher clinical pregnancy rates after fresh embryo transfer.
- Significantly higher cumulative live birth rates in the intervention group (61.9% vs. 30%, P=0.045).
Conclusions:
- Pre-IVF diet and exercise intervention leads to significant weight loss in obese women.
- Lifestyle modification significantly increases cumulative live birth rates in IVF cycles.
- Weight loss interventions may be beneficial for improving fertility outcomes in obese women.
Related Concept Videos
Drug Dosing: Obese Patients
314
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
314
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
322
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
322
Infertility in Females
4.9K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
4.9K
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
247
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
247
In Vitro Fertilization
1.1K
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
1.1K


